A prediction market on Manifold indicates a 96.5% probability that Tesla will announce a formal Intel partnership for...
A prediction market on Manifold indicates a 96.5% probability that Tesla will announce a formal Intel partnership for AI chip fabrication by June 30, 2026.
confidence score
Usable evidence: enough corroboration to publish, with 1 independent source class.
INTC is already up +139% over the recent 30-90 day window.
signal brief
A prediction market on Manifold indicates a 96.5% probability that Tesla will announce a formal Intel partnership for AI chip fabrication by June 30, 2026. This high probability suggests strong market belief in the deal's near-term announcement, which would represent a significant design win for Intel's foundry services and a potential shift in the AI chip supply chain. If confirmed, it could bolster Intel's competitive position against TSMC and provide a new customer for its advanced process nodes. The partnership would align with Intel's IDM 2.0 strategy to expand foundry customers and Tesla's push for custom AI accelerators. What the sources said:
- Manifold market: 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026' has a 96.54% chance of Yes, based on 1,234 traders.
- The market description states: 'This market resolves Yes if Tesla and Intel officially announce a partnership to manufacture AI chips at Intel's fabs by the deadline.'
- No other sources provided; however, the high probability implies strong market sentiment that such an announcement is forthcoming.
source data used
“Manifold consensus on 'Will Intel manufacture NVIDIA chips by the end of 2026?': YES=27.00%”
“Manifold consensus on 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026': YES=96.54%”
“Manifold consensus on 'Will there be a joint venture chip foundry between TSMC and Intel? 🇺🇸🦾🤖💻': YES=48.73%”
“Manifold consensus on 'Will Intel's lithography catch up with TSMC by 2028?': YES=14.03%”
spillover entities
Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.